The HIV Response After the Donor Shock: Africa's Real Test Is No Longer Money

How a 25% collapse in donor funding for HIV is forcing Africa to choose between managing a shortfall and redesigning a system.

In brief: Donor government funding for HIV fell 25% in 2025, the sharpest drop since the response began scaling up in the 2000s. The cut was driven almost entirely by the United States. Treatment numbers have held steady so far. Prevention, testing, and services for children and key populations have not — and that gap is the real story. This piece maps what changed, who is exposed, and what a sustainable HIV response now requires of African governments, donors, and communities.

The Number That Changed Everything

Donor governments gave $6.2 billion for HIV in low- and middle-income countries in 2025, down from $8.3 billion in 2024. That is a $2.1 billion drop — 25% in one year, and the steepest single-year fall since international HIV funding began scaling up. It is also the lowest funding level since 2007, according to the joint KFF–UNAIDS report released at the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro this July.

One country caused almost all of it. U.S. disbursements fell from $6.7 billion in 2024 to $4.6 billion in 2025, a 28% cut in bilateral aid driven by the dismantling of USAID and a new "America First Global Health Strategy." That $2.1 billion U.S. reduction matches the entire global decline.

This exposes a structural weakness nobody likes to discuss out loud: the HIV response was never as multilateral as it looked. The United States supplied about 74% of all donor government HIV funding in 2025, up from 59% in 2011. Every other donor government combined gave $1.6 billion in 2025 — half of what they gave in 2011. The world did not just lose money in 2025. It discovered how much of the architecture had been resting on one government's goodwill.

Call this what it is. Not a funding gap. A transition test.

A funding gap asks: who replaces the money?

A transition test asks a harder question: can African countries redesign HIV delivery fast enough to protect the gains already made, stop new infections from climbing back up, and build systems that do not wobble every time politics changes in Washington?

That second question is now Africa's to answer.

Why Ubuntu Is a Better Lens Than "Aid Dependency"

Development commentary loves the phrase "aid dependency." It is not wrong, but it is incomplete. It frames Africa as a passive recipient of Western generosity, waiting to be either rescued or abandoned.

Ubuntu — umuntu ngumuntu ngabantu, a person is a person through other persons — offers a sharper diagnostic tool. It says a health system's strength lies in its interdependence: the clinic depends on the community health worker, who depends on the peer educator, who depends on the person living with HIV who agreed to be tested in the first place. When donor money built parallel systems instead of strengthening this web of mutual obligation, it created a structure that could be switched off from outside. That is not a funding problem. It is a design problem.

Sankofa — go back and get it — points to the fix. Before donor-funded verticals arrived, African communities managed chronic illness, stigma, and care through networks of extended family, community elders, and mutual-aid structures. Community-led monitoring and peer outreach, the very services PEPFAR cuts hit hardest, are modern versions of that older logic. Rebuilding the HIV response on nationally owned, community-rooted foundations is not nostalgia. It is retrieving what worked before the response was reorganized around a single donor's fiscal year.

The Hidden Danger: Treatment Holds, Prevention Collapses

Globally, 41.0 million people were living with HIV in 2025. About 1.2 million people newly acquired HIV. Roughly 570,000 people died of AIDS-related illness. Some 32.1 million people were on antiretroviral therapy (ART) — the highest number ever, and proof the response still works when it is funded. These are UNAIDS's 2025 estimates, released alongside the KFF report at AIDS 2026.

Here is the trap: treatment numbers can look stable while everything feeding into future treatment quietly falls apart.

KFF's analysis of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)'s fourth-quarter FY2025 data — the first program-level PEPFAR data released since the 2025 disruptions — found that the number of people on ART held roughly steady compared with FY2024. But underneath that stability:

• HIV testing fell 17%
• New PrEP initiations fell 41%
• Adolescent girls and young women completing the DREAMS prevention package fell 86%, from 1.9 million to 253,400
• Children and family members served through PEPFAR's Orphans and Vulnerable Children program fell from 6.5 million to 1.7 million
• Cervical cancer screening among women on ART also declined

A country can keep people alive on treatment today while losing the outreach, testing, and prevention functions that stop tomorrow's infections. That is the quiet failure mode of this crisis. It does not show up in a headline. It shows up in five years of case data.

What the Front Line Is Reporting

Official data only tells part of the story, because PEPFAR itself stopped publishing most program data for three quarters of 2025. The amfAR PEPFAR Pulse Study, presented at AIDS 2026 by amfAR's Public Policy Office with Johns Hopkins Bloomberg School of Public Health, Funders Concerned About AIDS, and Data Etc., fills part of that gap. It surveyed 166 PEPFAR-funded organizations across 46 countries between April 2025 and April 2026.

The findings should concentrate the mind of every ministry of health:

• At least 1,714 HIV service sites closed after PEPFAR payments were terminated or delayed — 1,010 public health facilities, 325 access points, and 126 drop-in centers
• 73% of implementing partners stopped at least one service for key populations
• 67% stopped outreach services entirely
• Prevention spending fell 51% from FY2024 to FY2025
• 43% of partners permanently ended at least one prevention activity, including condom distribution and PrEP provision

This is not the same as official national surveillance data, and the study's authors are careful to say so. But it is a serious signal from the people closest to service delivery about where the system bends first: community outreach, key-population services, drop-in centers, peer networks, and the local organizations that reach people the formal clinic system does not.

Sub-Saharan Africa Carries the Weight

The WHO African Region held about 65% of all people living with HIV worldwide in 2024. It carries the deepest consequences when prevention weakens, treatment is interrupted, or data systems fail.

Fourteen countries deserve close, continuous attention: South Africa, Mozambique, Nigeria, Tanzania, Uganda, Kenya, Zambia, Zimbabwe, Malawi, Ethiopia, Eswatini, Lesotho, Botswana, and Namibia. They are not vulnerable in the same way. Some carry the heaviest disease burden. Some carry the heaviest donor dependence. Some have strong domestic financing but enormous absolute need. Some have made major treatment-cascade gains but remain exposed among adolescents, children, mobile populations, and key populations.

Ranking countries by HIV burden alone is no longer good enough. A useful transition map needs four layers of exposure:

1. Epidemiological exposure — where new infections, AIDS deaths, pediatric treatment gaps, and low viral suppression concentrate.
2. Financial exposure — which services depend most heavily on external funding.
3. Service-delivery exposure — which countries rely on community-led organizations, peer workers, mobile clinics, and donor-funded implementing partners to reach people outside the formal health system.
4. Political and legal exposure — where stigma, criminalization, anti-rights movements, or shrinking civic space make protecting key-population services harder.

A country can score low on disease burden and still be dangerously exposed on the other three. That is precisely the blind spot old rankings created.

Integration Is Not Automatically Progress

"Integrate HIV into primary health care" has become the reflexive answer to the funding shock. It is partly right. It is also a phrase that can hide a great deal of harm if nobody asks: integration into what, under whose control, financed how, with what safeguards?

If integration means a woman living with HIV can get antenatal care, viral-load monitoring, cervical cancer screening, contraception, and hypertension screening in one trusted visit, that is real progress.

If it means sex workers, gay men, transgender people, people who use drugs, prisoners, migrants, and adolescents disappear into generic clinics with high stigma and thin confidentiality, that is not integration. That is erasure with better paperwork.

On 1 July 2026, Rutgers and Aidsfonds – Soa Aids Nederland formally completed an administrative merger of their HIV, sexual health, rights, and research work, explicitly citing collapsing HIV funding and rising pressure on sexual and reproductive rights as the reason. That merger is one signal that some organizations are combining capability, not retreating from the mission. But a merger of institutions proves nothing about outcomes for people. The real test of integration is whether the most affected communities remain visible, funded, and protected — not whether two logos become one.

Children Are the Dashboard Light

In 2025, 1.3 million children aged 0–14 were living with HIV. Treatment access among children lags far behind adults — a gap that has proven stubborn even as pregnant women's access to ART to prevent transmission at birth has improved substantially. New HIV cases among children have fallen 69% since 2010, but that progress has stalled in recent years, and UNAIDS estimates almost half of children living with HIV still lack access to ART.

When children are missed, the whole system is sending a signal. It means antenatal care, early infant diagnosis, family testing, birth follow-up, community tracing, and pediatric treatment initiation are not working as designed. Pediatric HIV is not a side issue for a specialist committee. It is the dashboard light for the entire response — the first place a weakening system shows itself.

A Breakthrough Sitting on a Weak Delivery System

The science, at least, is moving. In July 2025, the World Health Organization recommended injectable lenacapavir — administered twice a year — as an additional PrEP option, alongside simplified testing approaches to support its rollout. For people who face stigma, long travel to clinics, or daily-pill fatigue, two injections a year could be transformative.

But a breakthrough product does not deliver itself. Lenacapavir will not reach adolescent girls, sex workers, men who have sex with men, transgender people, people who inject drugs, or serodifferent couples simply because it exists. It has to be financed, procured, delivered through channels people trust, targeted with good data, and made available without humiliation. Otherwise it becomes one more innovation that arrives in conference keynotes and never reaches a clinic shelf.

The System Is Being Redesigned Around Scarcity

UNAIDS's new Global AIDS Strategy 2026–2031 is explicit about the shift required: from an emergency, donor-driven response to one that is nationally led, rights-based, and embedded in resilient health and social systems. In June 2026, 149 member states adopted a political declaration aligned with the strategy's new 2030 targets: 40 million people on treatment and virally suppressed, 20 million people with access to antiretroviral-based prevention, and under 10% of people affected by HIV experiencing stigma, gender-based violence, or punitive legal environments.

The Global Fund's Eighth Replenishment tells the same story in numbers. It closed at $12.64 billion — a serious sum, and about $5 billion short of its $18 billion target, dragged down by a steep French cut and a delayed European Union pledge. The Global Fund Board has said resources will now concentrate on the poorest countries with the heaviest disease burden, alongside pooled procurement, market shaping, and community-led delivery.

Shared responsibility is not dead. But it has to be redesigned smaller, sharper, and less dependent on any single capital.

Ten Things African Governments Should Do Now

1. Protect treatment continuity. Nobody currently on ART should be lost to a financing transition.
2. Ring-fence prevention. Prevention is always the easiest line item to cut, because the people it protects are not yet visible as patients. That is exactly why it must be defended first.
3. Finance community-led delivery as infrastructure, not charity. Peer outreach is epidemic-control capacity.
4. Protect key populations. A response that abandons the people at highest risk cannot end AIDS, whatever the treatment numbers say.
5. Rebuild and own national HIV data systems. Data sovereignty is not a slogan. It is continuity insurance for the next shock.
6. Use transparent prioritization tools, such as TIER-Plus and related frameworks, to make funding trade-offs openly rather than by silent attrition.
7. Integrate carefully. Integration must add convenience without hiding vulnerable groups inside systems that were not built for them.
8. Protect pediatric HIV programs and treat children's outcomes as an early-warning indicator for the whole system.
9. Strengthen regional procurement and market shaping — pooled demand, local manufacturing where feasible, and harder price negotiation.
10. Publish transition scorecards. Citizens, parliaments, finance ministries, donors, and implementers all deserve to know what is being protected, what is being cut, and what that will cost.

A New Compact for Donors and Philanthropies

Donors should stop pretending every lost dollar will be replaced. It will not. But they can protect the parts of the system domestic budgets are least likely to defend fast enough: key-population services, community-led monitoring, pediatric case-finding, PrEP access, data migration, civil society infrastructure, bridge funding, and implementation science.

They should also stop treating "transition" as a workshop topic. Transition means budgets, institutions, data systems, procurement reform, workforce planning, legal protections, and hard political negotiation. It is a redesign of public-health architecture, not a panel discussion with good coffee.

The Real Question

Africa cannot replace U.S. funding overnight. That question answers itself.

The real question is whether African governments, donors, philanthropies, researchers, civil society, and regional institutions can use this shock to build something more durable than what existed before — a response that does not collapse every time one country's domestic politics shifts.

Treat this as a temporary shortfall, and the world will protect this year's treatment numbers while next year's infections quietly climb. Treat it as a transition test, and the goal of ending AIDS as a public health threat by 2030 stays within reach.

The future of HIV in Africa will not be decided in a laboratory. It will be decided in budgets, clinics, community networks, data systems, and procurement offices — in the ordinary, unglamorous work of the people who keep prevention and treatment running when the cameras from Rio have gone home.

Quick Answers

How much did HIV funding fall in 2025? Donor government funding fell $2.1 billion, or 25%, from $8.3 billion in 2024 to $6.2 billion in 2025 — the largest single-year drop since international HIV funding began scaling up, and the lowest level since 2007.

Who caused the decline? Almost entirely the United States. U.S. disbursements fell from $6.7 billion to $4.6 billion, a $2.1 billion cut that matches the full global decline. The U.S. still supplies about 74% of all donor government HIV funding.

Has HIV treatment collapsed? Not yet. The number of people on antiretroviral therapy has stayed roughly stable through FY2025. The damage is concentrated in testing (-17%), new PrEP initiations (-41%), and prevention programs for adolescent girls (-86%) and orphans and vulnerable children (from 6.5 million to 1.7 million served).

Which African countries are most exposed? South Africa, Mozambique, Nigeria, Tanzania, Uganda, Kenya, Zambia, Zimbabwe, Malawi, Ethiopia, Eswatini, Lesotho, Botswana, and Namibia carry the largest share of the epidemic and the widest range of exposure — epidemiological, financial, service-delivery, and political.

What should replace the old funding model? Nationally owned, community-rooted HIV systems with transparent domestic financing, protected prevention budgets, and shared — but no longer donor-dominated — international support, as set out in UNAIDS's Global AIDS Strategy 2026–2031.